| Simvastatin Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Simvastatin 10 mg | tablet | oral | 1.0 each | OTC |
| Simvastatin 20 mg | tablet | oral | 1.0 each | OTC |
| Simvastatin 40 mg | tablet | oral | 1.0 each | OTC |
| Simvastatin 5 mg | tablet | oral | 1.0 each | OTC |
| Simvastatin 80 mg | tablet | oral | 1.0 each | OTC |
Posted by purpleflamingo1 2 days ago
I started taking 20mg of Simvastatin on 10/17 due to high cholesterol. Five days later I came home from work feeling very ti...
Posted by suecar 10 days ago
I have been taking 20mg of Simvastatin every night for about 4 years now and after coming across this site I have decided to ...
Posted by joezen777 29 days ago
I'm only on 10mg Simvastatin and 10mg Lisinopril. I have type 1 diabetes and a minor TBI from a heat stroke. If I stop taki...
Switching From Losartan To Candesartan Achieves Significant ... - Medical News Today (press release)
1) Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years ...
Fri Mar 07 04:18:05 -0500 2008
Adding niacin better than doubling simvastatin dose - Pulse
Adding extended-release niacin to simvastatin improves lipid profiles more effectively than doubling the dose of simvastatin, say US researchers. ...
Tue Mar 04 04:44:46 -0500 2008
Sensex loses 939 pts at close - Sahara Samay
Simvastatin may also interact with the other, groups. AW was funded by diet alone. Symptoms of the potential modifying factors. Based on these data indicate ...
Mon Mar 03 06:15:55 -0500 2008
simvastatin - A lipid-lowering agent derived synthetically from a fermentation product of the fungus Aspergillus terreus. Hydrolyzed in vivo to an active metabolite, simvastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. This agent lowers plasma cholesterol and lipoprotein levels, and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. (NCI04)